Literature DB >> 30260256

Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.

Peter S Hendricks1.   

Abstract

A psychological model of classic psychedelic-assisted psychotherapy informed by contemporary scientific data is presented in this paper. It is suggested that classic psychedelic-occasioned mystical experience is characterized by profound awe, a discrete emotion experienced in the presence of a vast stimulus requiring accommodation of mental structures. Awe, in turn, promotes the small self, a construct that, in the extreme, is analogous to those of unitive experience and ego dissolution. The small self is conceptualized as key to understanding the downstream effects of mystical experience occasioned in the context of classic psychedelic-assisted psychotherapy. With this novel theoretical framework in mind, a number of clinical implications and recommendations are provided so as to advance this incipient field of study.

Keywords:  Psychedelics; awe; mechanisms of change; psilocybin; psychotherapy

Mesh：

Substances：

Year:  2018        PMID： 30260256     DOI： 10.1080/09540261.2018.1474185

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN： 0954-0261


  24 in total

Review 1.  Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Authors:  Sam G Moreton; Luke Szalla; Rachel E Menzies; Andrew F Arena
Journal:  Psychopharmacology (Berl)       Date:  2019-11-29       Impact factor: 4.530

2.  Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil.

Authors:  Dimitri Daldegan-Bueno; Lucas Oliveira Maia; Carolina Marcolino Massarentti; Luís Fernando Tófoli
Journal:  Psychopharmacology (Berl)       Date:  2022-02-18       Impact factor: 4.530

3.  Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.

Authors:  Elena Argento; M Eugenia Socias; Kanna Hayashi; JinCheol Choi; Lindsay Mackay; Devon Christie; M-J Milloy; Kora DeBeck
Journal:  Int J Drug Policy       Date:  2021-11-07

Review 4.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

5.  Associations between classic psychedelics and nicotine dependence in a nationally representative sample.

Authors:  Grant Jones; Joshua Lipson; Matthew K Nock
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

6.  Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.

Authors:  Alan K Davis; Frederick S Barrett; Roland R Griffiths
Journal:  J Contextual Behav Sci       Date:  2019-11-16

7.  Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

Authors:  Gabrielle Agin-Liebes; Trevor F Haas; Rafael Lancelotta; Malin V Uthaug; Johannes G Ramaekers; Alan K Davis
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-23

Review 8.  Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice.

Authors:  Jake E Payne; Richard Chambers; Paul Liknaitzky
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-16

9.  Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment.

Authors:  C J Healy; Kellie Ann Lee; Wendy D'Andrea
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-07-11

10.  Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.

Authors:  Dóra Révész; Genís Ona; Giordano N Rossi; Juliana M Rocha; Rafael G Dos Santos; Jaime E C Hallak; Miguel Á Alcázar-Córcoles; José C Bouso
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 5.435
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.